Brief: Thor Medical Signs LoI For Offtake With US, Scandinavian Based Clinical Trial Stage Cos
Nov 15 (Reuters) - Thor Medical ASA TRMED.OL :
* SIGNS LOI FOR OFFTAKE WITH US AND SCANDINAVIAN BASED CLINICAL TRIAL STAGE COMPANIES
* SAYS WE WILL TARGET TO DEVELOP AGREEMENTS INTO CONCRETE DELIVERY CONTRACTS AS PART OF WORK
TO
MAKE A FINAL INVESTMENT DECISION FOR OUR FIRST INDUSTRIAL-SCALE MANUFACTURING FACILITY IN 2025
Source text for Eikon: ID:nObitGK33a
Further company coverage: TRMED.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Thor Medical ASA
See all newsBrief: Thor Medical Enters Partnership Agreement With Minerva Imaging
Brief: Thor Medical Partners With Eckert & Ziegler
Brief: Thor Medical Completes Alphaone Production Facility At Herøya Industrial Park
Brief: Thor Medical Enters Multiyear Agreement With Node Pharma
Brief: Thor Medical H2 EBITDA Loss NOK 25.7 Mln